학술논문
Efficacy, safety, and treatment decision-making in the AVANTI German observational study of first-line bevacizumab (BEV)-containing therapy for locally advanced, recurrent, or metastatic breast cancer (aBC)
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
15387445